Literature DB >> 25608426

The validation of the Coping and Adaptation Processing Scale based on the Roy adaptation model.

Muder Alkrisat, Vivien Dee.   

Abstract

BACKGROUND AND
PURPOSE: To establish the psychometric soundness for Coping and Adaptation Processing Scale (CAPS) using the Roy adaptation model as theoretical framework.
METHOD: A descriptive, cross-sectional survey of a convenience sample of 199 nurses working in different acute health care facilities in California. The internal consistency of the multifactor CAPS questionnaire was explored using Cronbach's alpha coefficient. Factors correlation was examined using Pearson product moment correlation. The factor structure was studied using confirmatory factor analyses.
RESULTS: In the confirmatory factor analysis, the indices of fitness highly supported these results. The Cronbach's alpha coefficient for the total score was .81 and varied between .31 and .78 in the 5 domains. A positive and significant correlation emerged between CAPS factors and total scores (r = .91, p < .01) ranging from .17 to .81. CAPS showed acceptable validity and reliability for measuring the coping of nurses in acute setting. Future studies using the scale might lead to the improvement of the subscales measurement.
CONCLUSION: The psychometric data suggests that CAPS is a highly suitable instrument to measure coping processes.

Mesh:

Year:  2014        PMID: 25608426     DOI: 10.1891/1061-3749.22.3.368

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  2 in total

1.  Psychometric Testing of the Chinese Version of the Coping and Adaptation Processing Scale-Short Form in Adults With Chronic Illness.

Authors:  Xiyi Wang; Leiwen Tang; Doris Howell; Jing Shao; Ruolin Qiu; Qi Zhang; Zhihong Ye
Journal:  Front Psychol       Date:  2020-07-23

2.  Ideal Suggestions for Discharge Training and Telephone Counseling of Patients With Coronary Artery Bypass Graft Surgery: A Randomized Controlled and Experimental Study.

Authors:  Ufuk Kaya; Ümran Dal Yılmaz
Journal:  J Korean Med Sci       Date:  2022-09-05       Impact factor: 5.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.